Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity

International Journal of Pharmaceutics
Evren H GökçeCarla Caramella

Abstract

Cyclosporine A (CsA) loaded solid lipid nanoparticles (SLNs) for topical ophthalmic applications were prepared by high shear homogenization and ultrasound method using Compritol 888 ATO, Poloxamer 188 and Tween 80, to investigate the cellular uptake of rabbit corneal epithelial cells (RCE) and to evaluate the cytotoxicity. The size of the optimized formulation was 225.9+/-5.5 nm with a polydispersity index of 0.253+/-0.05. The zeta potential and entrapment efficiency was detected as -16.9+/-0.7 mV and 95.6%, respectively. The CsA release was found to be enzyme (lipase/co-lipase complex) dependent. SLNs were sterilized at 110 and 121 degrees C. The cytotoxicity was evaluated in vitro by means of RCE cells and was higher at 121 degrees C sterilization temperature, probably due to a supposed leakage of Tween 80 following lipid re-crystallization. The permeation and penetration of CsA across/into the corneal cells were evaluated using in vitro and ex vivo experiments. The cellular uptake was investigated by replacing CsA with the fluorescent dye Rhodamine B. The penetration enhancement properties were supported by confocal laser scanning microscopy analysis. The internalization of SLNs in cornea and in RCE cell lines was confirmed,...Continue Reading

References

Apr 16, 1998·Progress in Retinal and Eye Research·C L BourlaisR Leverge
May 20, 1999·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·A MidelfartJ Krane
May 9, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·V JenningS H Gohla
Jun 7, 2000·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·R H MüllerS Gohla
Sep 23, 2000·International Journal of Pharmaceutics·V JenningS H Gohla
Apr 20, 2001·Advanced Drug Delivery Reviews·W Mehnert, K Mäder
Feb 12, 2002·Pharmaceutical Research·Mitsuaki KuwanoYoichi Kawashima
May 9, 2002·International Journal of Pharmaceutics·Roberta CavalliM Fabrizio Saettone
Dec 14, 2002·International Journal of Pharmaceutics·Stephan Reichl, Christel C Müller-Goymann
Sep 19, 2003·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Angela M De CamposMaría J Alonso
Nov 7, 2003·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·F LallemandR Gurny
Jan 20, 2004·AAPS PharmSciTech·Y RanS H Yalkowsky
Jan 22, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Byung-Do KimHoo-Kyun Choi
Feb 3, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Susi BurgalassiPatrizia Chetoni
Apr 19, 2005·Methods and Findings in Experimental and Clinical Pharmacology·K ManjunathV Venkateswarlu
Jul 28, 2005·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·David Quintanar-GuerreroEric Doelker
Sep 15, 2005·Cancer Letters·Joanna PopiołkiewiczAleksander P Mazurek
Apr 4, 2006·International Journal of Pharmaceutics·R H MüllerE B Souto
Aug 29, 2006·Drug Discovery Today·Jagdish L ItaliaM N V Ravi Kumar
Oct 12, 2007·International Journal of Pharmaceutics·Shan RenBeom-Jin Lee

❮ Previous
Next ❯

Citations

Feb 18, 2014·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Slavomira DoktorovovaAmélia M Silva
Jul 25, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Christoph LuschmannAchim Goepferich
Feb 21, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ketan HippalgaonkarSoumyajit Majumdar
Jan 5, 2013·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ana del Pozo-RodríguezMaria Ángeles Solinís
Sep 22, 2010·International Journal of Nanomedicine·Zaida Urbán-MorlánDavid Quintanar-Guerrero
Jul 1, 2010·Therapeutic Delivery·Evren H GokceEliana B Souto
Aug 12, 2014·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Neslihan Ustündağ-OkurGökhan Ertan
Jun 24, 2009·Journal of Microencapsulation·Ebru BaşaranYasemin Yazan
Jun 11, 2015·Journal of Functional Biomaterials·Yuhong WangRaju V S Rajala
May 25, 2010·Drug Delivery·Ali SeyfoddinRaida Al-Kassas
Mar 20, 2012·Drug Development and Industrial Pharmacy·Ali Seyfoddin, Raida Al-Kassas
Mar 9, 2011·Expert Opinion on Drug Metabolism & Toxicology·Stephan ReichlJessica Verstraelen
Aug 26, 2014·Expert Opinion on Drug Delivery·Mona H Aburahma, Shaimaa M Badr-Eldin
Jul 6, 2010·Current Eye Research·Eliana B SoutoMaria Luisa Garcia
Mar 27, 2012·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Claudia Di TommasoMichael Möller
Oct 11, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R LopesA J Almeida
Apr 5, 2011·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Silvia PetersenHeike Bunjes
Mar 9, 2010·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M NassimiC Müller-Goymann
Oct 27, 2015·International Journal of Pharmaceutics·Noha S El-SalamouniSafaa S El-Gamal
Nov 27, 2015·Therapeutic Delivery·Rosario PignatelloGiovanni Puglisi
Sep 2, 2015·International Journal of Pharmaceutics·Shilpa KakkarIndu Pal Kaur
Nov 28, 2012·Journal of Biomedical Materials Research. Part a·Mohd Abul KalamAws Alshamsan
Jan 16, 2010·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Tarl W Prow
Dec 21, 2012·Journal of Biomedical Materials Research. Part a·Mohd Abul KalamAws Alshamsan
Mar 29, 2011·Annales pharmaceutiques françaises·C Di TommasoM Möller
Jul 24, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Jifu HaoQiang Zhang
Jun 15, 2014·International Journal of Pharmaceutics·Kris HermansAnnick Ludwig
Apr 9, 2014·Nanomedicine : Nanotechnology, Biology, and Medicine·Melissa A VettenMary Gulumian
Aug 16, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Slavomira DoktorovováEliana B Souto
Oct 30, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·E Sánchez-LópezM L García
Oct 30, 2016·Therapeutic Delivery·Hasan Ali, Sandeep Kumar Singh
Nov 7, 2016·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Malgorzata SznitowskaJustyna Pietkiewicz
Jun 14, 2016·Expert Opinion on Drug Delivery·Luigi BattagliaMaria Angeles Solinis
Apr 11, 2017·Advanced Drug Delivery Reviews·Dileep R JanagamTao L Lowe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.